161 related articles for article (PubMed ID: 7712429)
1. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas.
Lauwers GY; Scott GV; Karpeh MS
Cancer; 1995 May; 75(9):2209-13. PubMed ID: 7712429
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].
Lee DS; Kang SB; Baek JT; Nam SW; Lee KM; Ahn BM; Lee EH; Han SW; Chung IS
Korean J Gastroenterol; 2005 Jun; 45(6):394-400. PubMed ID: 15973073
[TBL] [Abstract][Full Text] [Related]
3. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia.
Lauwers GY; Scott GV; Hendricks J
Cancer; 1994 Jun; 73(12):2900-4. PubMed ID: 8199986
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis.
Kolodziejczyk P; Yao T; Oya M; Nakamura S; Utsunomiya T; Ishikawa T; Tsuneyoshi M
Cancer; 1994 Dec; 74(11):2896-907. PubMed ID: 7954254
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study.
Koshida Y; Saegusa M; Okayasu I
Br J Cancer; 1997; 75(3):367-73. PubMed ID: 9020481
[TBL] [Abstract][Full Text] [Related]
8. [Expression of MIB-1/KI-67 and bcl-2 in gastric carcinoma. Relationship with clinico-pathological factors].
Sundblad AS; Tamayo R
Acta Gastroenterol Latinoam; 1995; 25(2):67-72. PubMed ID: 8525762
[TBL] [Abstract][Full Text] [Related]
9. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Chalkley L; Karagiannis J; Paraskeva K; Mathou N; Dellaporta E; Tsianos E; Agnantis NJ
Acta Gastroenterol Belg; 2007; 70(3):285-9. PubMed ID: 18074738
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of bcl-2 expression in gastric cancer.
Müller W; Schneiders A; Hommel G; Gabbert HE
Anticancer Res; 1998; 18(6B):4699-704. PubMed ID: 9891543
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
14. [Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma].
Lee SW; Kang SB; Kim YS; Nam SW; Lee DS; Lee HK; Han SW
Korean J Gastroenterol; 2007 Mar; 49(3):152-7. PubMed ID: 18172343
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?
Kopp R; Diebold J; Dreier I; Cramer C; Glas J; Baretton G; Jauch KW
Surg Endosc; 2005 Nov; 19(11):1507-12. PubMed ID: 16177872
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
19. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Soslow RA; Remotti H; Baergen RN; Altorki NK
Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
[TBL] [Abstract][Full Text] [Related]
20. [Expression of survivin in human gastric adenocarcinomas: correlation with proliferation and apoptosis].
Yao XQ; Liu FK; Qi XP; Wu B; Yin HL; Ma HH; Shi QL; Zhou XJ; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):145-8. PubMed ID: 15062058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
